U
Ulrich Bogdahn
Researcher at University of Regensburg
Publications - 347
Citations - 36060
Ulrich Bogdahn is an academic researcher from University of Regensburg. The author has contributed to research in topics: Neural stem cell & Neurogenesis. The author has an hindex of 67, co-authored 344 publications receiving 32279 citations. Previous affiliations of Ulrich Bogdahn include Hoffmann-La Roche & Volkswagen Foundation.
Papers
More filters
Journal ArticleDOI
Observation on the integrity of the blood-brain barrier after microbubble destruction by diagnostic transcranial color-coded sonography.
Felix Schlachetzki,Thilo Hölscher,Horst J. Koch,Bogdan Draganski,Arne May,Gerhard Schuierer,Ulrich Bogdahn +6 more
TL;DR: To investigate alteration of the blood‐brain barrier from ultrasonic contrast agent destruction by diagnostic transcranial color‐coded sonography using gadolinium‐enhanced magnetic resonance imaging.
Journal ArticleDOI
Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
TL;DR: A 54-year-old patient who had received his last booster vaccination 3 years before developing a severe TBE with delayed induction and longterm persistence of anti-TBEV-IgM-antibodies is reported on.
Journal ArticleDOI
Imaging of the vertebrobasilar system by transcranial color-coded real-time sonography
TL;DR: TCCS of the vertebrobasilar system will improve reliability of transcranial sonographic examination, and the assignment of the obtained flow signals to specific vascular segments was improved by this new technique.
Journal ArticleDOI
Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms.
Verena Leidgens,Corinna Seliger,Birgit Jachnik,Tobias Welz,Petra Leukel,Arabel Vollmann-Zwerenz,Ulrich Bogdahn,Marina Kreutz,Oliver M. Grauer,Peter Hau +9 more
TL;DR: It is postulate that ibuprofen may inhibit tumor cells also by COX- and lactate-independent mechanisms after long-term treatment in physiological dosages, whereas diclofenac mainly acts by inhibition of STAT-3 signaling and downstream modulation of glycolysis.
Journal ArticleDOI
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Dagmar Beier,Dagmar Beier,Martin Proescholdt,Christiane Reinert,Torsten Pietsch,David T.W. Jones,Stefan M. Pfister,Stefan M. Pfister,Elke Hattingen,Clemens Seidel,Linda Dirven,Ralf Luerding,Jaap C. Reijneveld,Monika Warmuth-Metz,Matteo Mario Bonsanto,Michael Bremer,Stephanie E. Combs,Stephanie E. Combs,Stefan Rieken,Ulrich Herrlinger,Holger Kuntze,Regine Mayer-Steinacker,Dag Moskopp,Thomas Schneider,Andreas Beringer,Uwe Schlegel,Walter Stummer,Helmut Welker,Astrid Weyerbrock,Frank Paulsen,Stefan Rutkowski,Michael Weller,Wolfgang Wick,Rolf-Dieter Kortmann,Ulrich Bogdahn,Peter Hau +35 more
TL;DR: Radio-polychemotherapy did lead to considerable toxicity and a high amount of dose reductions throughout the first 4 chemotherapy cycles that may affect efficacy, and frequent patient surveillance is proposed using this regimen.